Decreased survival and increased recurrence in Merkel cell carcinoma significantly linked with immunosuppression.

Mary K BryantChristine WardCharles E GaberPaula D StrassleDavid W OllilaShachar Laks

Published in: Journal of surgical oncology (2020)

Immunocompromised patients had a threefold increased incidence of 5-year mortality and over twofold increased incidence of any recurrence as non-immunocompromised patients. Patients' immunosuppressive status should be considered when making decisions regarding treatment, surveillance, and prognostication.

Keyphrases

newly diagnosed
ejection fraction
prognostic factors
risk factors
public health
cardiovascular disease
patient reported outcomes
chronic kidney disease
acute respiratory distress syndrome